EPIK

Granite Telecommunications Boosts EPIK Solution with Strategic Rapid Response Monitoring Alliance

Retrieved on: 
Tuesday, April 9, 2024
Communication, POTS, Plain old telephone service, Box, Partnership, Telecommunications, City, Central office, Granite, Safety, EPIK, AHJ, Fire department, NFPA, NFPA 72

QUINCY, Mass., April 9, 2024 /PRNewswire-PRWeb/ -- Granite Telecommunications, a leading $1.85 billion provider of communications and technology solutions to businesses and government entities, proudly announces a strategic partnership with Rapid Response Monitoring. This collaboration is set to offer top-tier professional monitoring services for customers utilizing Granite's patented EPIK solution for alarm signaling.

Key Points: 
  • QUINCY, Mass., April 9, 2024 /PRNewswire-PRWeb/ -- Granite Telecommunications , a leading $1.85 billion provider of communications and technology solutions to businesses and government entities, proudly announces a strategic partnership with Rapid Response Monitoring .
  • This collaboration is set to offer top-tier professional monitoring services for customers utilizing Granite's patented EPIK solution for alarm signaling.
  • "In forging this partnership with Rapid Response Monitoring, we're not just enhancing a product; we're elevating the entire safety and security landscape for our customers.
  • "Our alliance with Granite is a testament to our shared commitment to excellence and innovation," said Jeffrey Atkins, President of Rapid Response Monitoring.

Granite Telecommunications Continues Reign as Lightstream's Network Partner of the Year for 2023

Retrieved on: 
Wednesday, March 6, 2024
Cloud, EPIK, Telecommunications, Emerging, POTS, Platinum, Granite, Partner, Fortune 1000, Distribution, Partnership

QUINCY, Mass., March 6, 2024 /PRNewswire-PRWeb/ -- Granite Telecommunications, a leading $1.85 billion provider of communications and technology solutions to businesses and government entities, has been honored as Lightstream's Network Partner of the Year for 2023, marking the second consecutive year Granite has received this prestigious accolade. Following its 2022 win as Platinum Network Partner of the Year, Granite continues to set the standard for excellence in network services and partnerships.

Key Points: 
  • Following its 2022 win as Platinum Network Partner of the Year, Granite continues to set the standard for excellence in network services and partnerships.
  • Granite's repeat honor underscores its leading position in the network services domain, showcasing its commitment to providing robust support and reliable solutions.
  • "We are thrilled to be named Lightstream's Network Partner of the Year for the second year in a row," said Rob Hale, President and CEO of Granite Telecommunications.
  • Lightstream's Network Operations Practice Lead, Brian Rhees, spotlighted Granite Telecommunications for its pivotal role in their achievements, saying, "A massive shout out to Granite Telecommunications, our Network Partner of the Year!

EPIK Introduces 'AI Christmas' to Continue AI Yearbook Boom

Retrieved on: 
Tuesday, December 12, 2023
Christmas, SNOW, Social media, AI, Multimedia, EPIK, Medical device, Online shopping

This service was launched as an extension of the 'AI Yearbook', which became a global craze after its first release in September.

Key Points: 
  • This service was launched as an extension of the 'AI Yearbook', which became a global craze after its first release in September.
  • It is reported that about 30,000 global users have used AI Christmas within a week of its release.
  • Just like AI Yearbook, users can receive 30 American-style Christmas photos by uploading 8-12 selfies they took themselves.
  • To use AI Christmas, simply open the EPIK app and select the "AI Christmas" tab.

EPIK's AI Yearbook to Become No.1 Online Phenomenon…Ranked No.1 in 56 countries on App Store

Retrieved on: 
Tuesday, October 10, 2023
Express, United Kingdom, AI, EPIK, SNOW, Research, Standard, Online shopping

AI Yearbook is one of the features offered by the EPIK app, which generates 60 images in the style of 1990s American yearbook albums using 8 to 12 selfie photos as input.

Key Points: 
  • AI Yearbook is one of the features offered by the EPIK app, which generates 60 images in the style of 1990s American yearbook albums using 8 to 12 selfie photos as input.
  • EPIK topped app stores in 56 countries and regions around the world, including the United States, France, the United Kingdom, Hong Kong SAR, and Thailand.
  • This will allow users to enjoy the AI Yearbook service without worrying about the leakage of personal information.
  • The AI Yearbook concept was created by the EPIK team as part of a separate research project.

EPIK's AI Yearbook to Become No.1 Online Phenomenon…Ranked No.1 in 56 countries on App Store

Retrieved on: 
Tuesday, October 10, 2023
Multimedia, Express, United Kingdom, AI, EPIK, SNOW, Research, Standard, Online shopping

AI Yearbook is one of the features offered by the EPIK app, which generates 60 images in the style of 1990s American yearbook albums using 8 to 12 selfie photos as input.

Key Points: 
  • AI Yearbook is one of the features offered by the EPIK app, which generates 60 images in the style of 1990s American yearbook albums using 8 to 12 selfie photos as input.
  • EPIK topped app stores in 56 countries and regions around the world, including the United States, France, the United Kingdom, Hong Kong SAR, and Thailand.
  • This will allow users to enjoy the AI Yearbook service without worrying about the leakage of personal information.
  • The AI Yearbook concept was created by the EPIK team as part of a separate research project.

Xenon Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update

Retrieved on: 
Tuesday, May 9, 2023
Epilepsy, EPIK, MPC, Icahn School of Medicine at Mount Sinai, DBP, Clinical trial, Neurocrine Biosciences, DSM-IV codes, Neurocrine, SCN8A, Research, Mount Sinai, ID, MADRS, FOS, MDD, Patient, Grammatical mood, Seizure, Webcast, Ageing, FDA, OLE, Safety, Nursing, Pharmaceutical industry, Video game, Xenon

VANCOUVER, British Columbia, May 09, 2023 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today reported financial results for the first quarter ended March 31, 2023 and provided a corporate update.

Key Points: 
  • VANCOUVER, British Columbia, May 09, 2023 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today reported financial results for the first quarter ended March 31, 2023 and provided a corporate update.
  • We expect patient screening to be completed in June with the release of topline data in the fourth quarter.
  • No revenue was recognized in the first quarter of 2023, compared to $8.8 million for the same period in 2022.
  • Xenon will host a conference call and webcast today at 4:30 pm Eastern Time (1:30 pm Pacific Time) to discuss its first quarter 2023 results.

A Celebrity Favorite and Home to the PGA Tour Mexico Open, Vidanta Nuevo Vallarta is an Extraordinary Resort with Luxe Accommodations

Retrieved on: 
Thursday, April 27, 2023
EPIK, Heart, Human, Music, Travel, Crater, PGA Tour, The Ricki Lake Show (2012 talk show), Golf, VidantaWorld, Pacific Ocean, Restaurant, Love, PGA, Official World Golf Ranking, Tourism, Management, Hotel, Amusement park, Grupo Vidanta

PGA TOUR Senior Vice President, Tournament Business Affairs congratulates Vidanta for being extraordinary.

Key Points: 
  • PGA TOUR Senior Vice President, Tournament Business Affairs congratulates Vidanta for being extraordinary.
  • VIDANTA, Mexico, April 27, 2023 /PRNewswire/ -- Surrounded by the mountains, the river, and the Pacific Ocean, lies one of the most amazing and welcoming hotels in the world, Vidanta Nuevo Vallarta , home of the official PGA TOUR Mexico Open at Vidanta.
  • Vidanta Nuevo Vallarta is a favorite destination amongst professional golfer players, celebrities, and families worldwide who are looking to enjoy their vacation in true Vidanta-style luxury.
  • 1 in the Official World Golf Ranking and defending champion of the PGA TOUR Mexico Open at Vidanta.

Granite Receives 2023 INTERNET TELEPHONY Product of the Year Award

Retrieved on: 
Friday, March 17, 2023
Telecommunications, EPIK, Ernst & Young Entrepreneur of the Year Award, INTERNET, Building, POTS, LTE, IP, PCI, TMC, Managed facilities-based voice network, Government, HIPAA, Safety, Mobile phone, Granite

QUINCY, Mass., March 17, 2023 /PRNewswire-PRWeb/ -- Granite Telecommunications, a $1.8 billion provider of communications and technology solutions to multi-location businesses and government agencies, announced today that TMC, a global, integrated media company, has named Granite EPIK as a recipient of a 2023 INTERNET TELEPHONY Product of the Year Award.

Key Points: 
  • QUINCY, Mass., March 17, 2023 /PRNewswire-PRWeb/ -- Granite Telecommunications , a $1.8 billion provider of communications and technology solutions to multi-location businesses and government agencies, announced today that TMC , a global, integrated media company, has named Granite EPIK as a recipient of a 2023 INTERNET TELEPHONY Product of the Year Award.
  • "We're thrilled that Granite EPIK has been honored with a INTERNET TELEPHONY Product of the Year Award," said Granite President and CEO Rob Hale.
  • "I am honored to recognize Granite with a 2023 Product of the Year Award for its commitment to excellence and innovation," said Rich Tehrani , CEO, TMC.
  • The winners of the 2023 INTERNET TELEPHONY Product of the Year will be featured in INTERNET TELEPHONY magazine online and on TMCnet.

Xenon Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update

Retrieved on: 
Wednesday, March 1, 2023
KCNQ2, Mount Sinai, Patient, MADRS, Seizure, SCN8A, DBP, Grammatical mood, Channel modulator, Icahn School of Medicine at Mount Sinai, MRI, Ageing, Epilepsy, Depression, Neurocrine Biosciences, MDD, MPC, DSM-IV codes, FOS, OLE, EPIK, Magnetic resonance, SLC6A1 epileptic encephalopathy, Safety, Webcast, Research, Anhedonia, Physician, ID, Pharmaceutical industry, Cryptocurrency, Xenon

BURNABY, British Columbia, March 01, 2023 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today reported financial results for the fourth quarter and full year ended December 31, 2022 and provided a corporate update.

Key Points: 
  • BURNABY, British Columbia, March 01, 2023 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today reported financial results for the fourth quarter and full year ended December 31, 2022 and provided a corporate update.
  • Topline results from the X-NOVA study are anticipated in the third quarter of this year.
  • No revenue was recognized in the fourth quarter of 2022, and $9.4 million for the year ended 2022, compared to $3.7 million and $18.4 million for the same periods in 2021, respectively.
  • Xenon will host a conference call and webcast today at 4:30 pm Eastern Time (1:30 pm Pacific Time) to discuss its fourth quarter and full year 2022 results.

Xenon Pharmaceuticals Outlines Key Milestone Opportunities for 2023

Retrieved on: 
Monday, January 9, 2023
OLE, Ageing, SCN8A, Depression, Seizure, Icahn School of Medicine at Mount Sinai, Safety, FDA, FOS, MADRS, MPC, MDD, NDA, Grammatical mood, DBP, EPIK, Patient, Neurocrine Biosciences, Epilepsy, MRI, KCNQ2, Anhedonia, Magnetic resonance, Neurocrine, Mount Sinai, Medical imaging, Pharmaceutical industry, Xenon

BURNABY, British Columbia, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today outlined recent progress in its clinical programs and key milestones for 2023.

Key Points: 
  • BURNABY, British Columbia, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today outlined recent progress in its clinical programs and key milestones for 2023.
  • Xenon has initiated a Phase 3 clinical trial, called X-ACKT, to support potential regulatory submissions in an additional epilepsy indication of primary generalized tonic clonic seizures (PGTCS).
  • The primary efficacy endpoint is the MPC in monthly PGTCS frequency from baseline through the DBP of XEN1101 compared to placebo.
  • Pursuant to the terms of the agreement, Xenon has the potential to receive certain clinical, regulatory, and commercial milestone payments, as well as future sales royalties.